The Effects of Strawberry Supplementation on Memory and Gait Among Over-weight Older Adults (NCT03162913) | Clinical Trial Compass
CompletedNot Applicable
The Effects of Strawberry Supplementation on Memory and Gait Among Over-weight Older Adults
United States47 participantsStarted 2017-10-01
Plain-language summary
This study is being conducted to assess the effect of dietary strawberry supplementation on cognition and mobility in obese middle-aged and older adults. It is hypothesized that plant compounds, present in strawberries, may improve cognition and mobility.
Who can participate
Age range55 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Between the ages of 55 and 75 years
* Body mass index (BMI) between 30-40
* Hemoglobin A1C level between 5.7 and 6.4%
* Height between 60 and 74 inches tall
* Adequate visual acuity or corrected visual acuity to read and perform computer tasks
* Fluency in spoken and written English
* Ability to walk independently for 20 minutes as per self-report.
* Women must be postmenopausal (absence of menstruation for a minimum of 12-months or bilateral oophorectomy)
* Willing to abstain from recreational drug use
Exclusion Criteria:
* Vegetarian or vegan
* Cognitive impairment, memory loss, or neurologic/psychological disorder that interfere with activities of daily living
* Muscle or mobility deficit that would interfere with walking independent for 20 minutes
* Chronic conditions associated with increased risk of falls or falls within the last year that were not precipitated by unusual circumstances (e.g. slipping on ice, being pushed)
* Gastrointestinal diseases, conditions, or medications influencing gastrointestinal absorption
* Use of medications or dietary supplements known or suspected to influence study outcomes
* Mini Mental State Exam (MMSE) score of less than 24 at screening
* Diabetes mellitus diagnosis or fasting glucose \>= 126 mg/dL or taking diabetes medication
* Liver dysfunction, history of cirrhosis, or elevated SGPT, SGOT, or total bilirubin
* Kidney disease as indicated by serum creatinine \> 1.5 mg/dL at screening
* Uncontrolled blood pre…
What they're measuring
1
Spatial Cognition
Timeframe: Change from baseline at 90 days
Trial details
NCT IDNCT03162913
SponsorUSDA Human Nutrition Research Center on Aging